Advances In Clinical And Experimental Medicine, cilt.31, ss.1-9, 2022 (SCI-Expanded)
Background. Cyclophosphamide is a drug used in various types of cancer. It can cause oxidative and
inflammatory ovarian damage and infertility. Thiamine pyrophosphate (TPP) tobe investigated for its effect
oncyclophosphamide-induced ovarian damage and reproductive dysfunction inthepresent study istheactive
metabolite of thiamine. It has been shown that TPP protects organs and tissues from oxidative stress and
proinflammatory cytokine damage.
Objectives. To investigate the effect of TPP against the ovarian damage and reproductive dysfunction
caused bycyclophosphamide inrats.
Materials and methods. Albino Wistar type female rats were divided into healthy control (HG), cyclophosphamide (CYC) and TPP + cyclophosphamide (TPPC) groups (for each group, n=12). Thiamine pyrophosphate atadose of25 mg/kg was injected intraperitoneally (ip.) intheTPPC group, and 0.9% NaCI solution
was injected ip. intheCYC and HG groups. One hour after theinjection, 75mg/kg ofcyclophosphamide was
administered ip. intheTPPC and CYC groups. This procedure was repeated once aday for 30days. At theend
of this period, 6rats from each group were euthanized with ahigh dose ofanesthetic (50 mg/kg of sodium
thiopental). Biochemical and histopathological examinations were performed ontheextracted ovarian tissue.
Theremaining animals were kept inthelaboratory with mature male rats for 2 months for reproduction.
Results. Thiamine pyrophosphate significantly decreased thecyclophosphamide-induced increase inthelevels of the oxidant parameter malondialdehyde (MDA), proinflammatory nuclear factor kappa B (NF-κB),
tumor necrosis factor alpha (TNF-α), and interleukin 1 beta (IL-1β). In addition, TPP decreased the severe
histopathological damage associated with cyclophosphamide intheovarian tissue and prevented infertility.
Conclusions. Our experimental results have suggested that TPP could be beneficial in the treatment
of cyclophosphamide-induced ovarian injury and infertility.